The Sodium Iodide Symporter and Breast Cancer
Author Information
Author(s): Ryan James, Curran Catherine E., Hennessy Emer, Newell John, Morris John C., Kerin Michael J., Dwyer Roisin M.
Primary Institution: National University of Ireland Galway
Hypothesis
This study aimed to quantify relative expression of NIS and putative regulators in human breast tissue.
Conclusion
NIS expression is significantly higher in malignant compared to normal breast tissue, with the highest level detected in fibroadenoma.
Supporting Evidence
- NIS expression was detectable in 98 out of 100 samples analyzed.
- Significantly higher levels of NIS were observed in fibroadenoma and malignant breast tissue compared to normal tissue.
- Positive correlations were found between NIS and various receptors, including ERα and RARα.
Takeaway
The study found that a protein called NIS is more common in cancerous breast tissue than in normal tissue, and even more so in benign tumors called fibroadenomas.
Methodology
Human breast tissue specimens were analyzed by RQ-PCR targeting NIS and various receptors, and breast cancer cells were treated with different ligands to analyze changes in NIS expression.
Potential Biases
Potential bias in sample selection and the reliance on specific methodologies for analysis.
Limitations
The study's findings may not apply to all breast cancer types due to the specific cohort used.
Participant Demographics
{"malignant":{"count":75,"premenopausal":24,"postmenopausal":51,"mean_age":57},"fibroadenoma":{"count":10,"premenopausal":9,"postmenopausal":1,"mean_age":36},"normal":{"count":15,"premenopausal":12,"postmenopausal":3,"mean_age":48}}
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website